Hope for Alzheimer’s: Anti-inflammatory drugs show promise
In recent years, scientists have been exploring various ways to treat Alzheimer's disease (AD).
One such research comes from Dr. Linda Van Eldik's lab at...
New guidelines for Alzheimer’s disease diagnosis through blood biomarkers
Today at the International Alzheimer's Congress (AAIC) in Amsterdam, new guidelines for the diagnosis of Alzheimer's disease were unveiled.
These criteria, developed by international clinicians...
A ray of hope: new methods to treat Alzheimer’s disease
Alzheimer's disease is a common brain disorder that affects memory and thinking skills.
It can be heartbreaking to see loved ones slowly forget their family...
Understanding big causes of dementia
Dementia can change a person's life. It can mess with their memory, thinking, emotions, and even behavior. It makes daily tasks a challenge.
Dementia isn't...
Traffic-related air pollution linked to Alzheimer’s disease, study finds
In a recent study, researchers found that exposure to traffic-related air pollution led to memory loss, cognitive decline, and triggered neurological pathways associated with...
Sleeping pill lowers key Alzheimer’s disease markers, study finds
A small study has discovered that taking a sleeping pill before bed can lead to a decrease in levels of key Alzheimer's proteins.
This is...
Artificial intelligence: a new hope for early Alzheimer’s prediction
Alzheimer's disease is a serious problem. It affects millions of people, especially older adults. It harms the brain and makes it hard for people...
Spotting early signs of memory loss through the eye
Researchers at Duke Health have come up with a clever way to tell if someone might be starting to have memory problems.
They can do...
A new hope in the fight against Alzheimer’s disease
The Problem at Hand
We've all heard about Alzheimer's, a disease that affects a person's memory and thinking. It makes it hard for people to...
Young-onset Alzheimer’s can be diagnosed from as early as 30 – and the symptoms...
Alzheimer’s disease is often thought of as a condition that only affects the elderly.
But around 3.9 million people worldwide aged 30-64 live with young-onset...